Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
43.01%EBITDA Margin
VS
Market
Sector
Industry
History
$ 12.16Close
$ 5.86 - $ 16.56 52-Week Range
Ticker Information
Ticker
CRMDCompany Name
CORMEDIX INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCORMEDIX INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CRMD - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 52.25M | 43.01% | $ 121.48M |
| 3/31/2025 | $ 17.67M | 21.4% | $ 82.55M |
| 12/31/2024 | $ -18.98M | -43.66% | $ 43.47M |
| 9/30/2024 | $ -47.32M | -385.86% | $ 12.26M |
| 6/30/2024 | $ -54.34M | -6740.88% | $ 806.12K |
| 3/31/2024 | $ -51.52M | 0% | $ 0 |
| 12/31/2023 | $ -46.23M | 0% | $ 0 |
| 9/30/2023 | $ -39.68M | -133603.91% | $ 29.7K |
| 6/30/2023 | $ -36.79M | -100750.97% | $ 36.52K |
| 3/31/2023 | $ -33.71M | -58348.7% | $ 57.77K |
Key Performance Insights, Last 5 Years
- CORMEDIX INC's latest trailing twelve months (TTM) EBITDA % stands at -12631.32%.
- Over the past 5 years, CORMEDIX INC's average EBITDA % has been -28102.88%.
- The median EBITDA % for CORMEDIX INC during this period was -13569.94%
- CORMEDIX INC reached its highest EBITDA % over the past 5 years at 43.01%.
- The lowest EBITDA % recorded by CORMEDIX INC in the same timeframe -133603.91%
CORMEDIX INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for CORMEDIX INC is calculated as follows: EBITDA [ $ -26.31M ] / Revenues [ $ 208.29K ]
(=) EBITDA % [ -12631.32% ] CRMD - EBITDA Margin, Last 5 years
-133603.91%
Minimum
Sep 30, 2023
43.01%
Maximum
Jun 30, 2025
-28102.88%
Average
-13569.94%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -75.07% |
| max | 97.73% |
| average | 16.12% |
| median | 14.72% |
| std | 26.88% |